Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Iii Thomas Charles Bernhardt > Profile

Iii Thomas Charles Bernhardt

Affiliations

  • Interim Cfo at Cellectar Biosciences Inc. (CLRB), 2019-03-11
  • Interim Cfo at Echo Therapeutics Inc. (ECTE), 2014-07-30
  • Chief Financial Officer at Hemispherx Biopharma Inc (HEB), 2011-12-22
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
HEB $0.59 198,135 $117,295.92 265,214 2010-06-15 Filing
HEB $0.56 2,000 $1,125.80 67,079 2009-12-07 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
HEB $0.59 87,794 $51,974.05 177,420 2010-06-15 Filing